Actualités
Expanding Access to Nilotinib in Low-Income Countries
Following the agreement on a new licensing model between the Medicines Patent Pool (MPP) & Novartis in collaboration with the ATOM Coalition, generic, quality-assured nilotinib is now available on NCDconnect! This initiative is crucial in making lifesaving...
Comment s'inscrire sur NCDconnect : un Processus Simple et Rapide
Welcome to NCDconnect, your Digital Procurement Platform for essential medicines and medical devices against noncommunicable diseases (NCD). Signing up is straightforward, and this guide will help you complete the process with ease. For visual assistance, check out...
Childhood Cancer Medicines: Improving Access in LMICs
Every child deserves a fighting chance against cancer, regardless of where they are born. Yet, stark inequalities persist in access to pediatric oncology treatment, especially in low- and middle-income countries (LMICs). As purchasers responsible for securing...
Sickle Cell Disease: How to Support 14 Million Lives Affected by 2050
Sickle Cell Disease (SCD) is a genetic blood disorder that affects millions of people worldwide. Between 2010 and 2050, an estimated 14 million babies will be affected globally, with the vast majority born in low- and middle-income countries (LMICs). This staggering...
Brand-Name and Generic Medicines: 2 Sides of the Same Coin
Access to essential treatments is a cornerstone of effective healthcare systems. Both brand-name medicines and generics play vital roles in ensuring that patients receive the care they need. While brand-name medicines are often associated with innovation and...
How are these 6 Countries Improving Accessibility of Cancer Care?
Success in improving access to cancer care is not about a one-size-fits-all approach; it involves addressing unmet needs with high-impact actions. In its comprehensive white paper, Improving Access to Affordable and Sustainable Oncological Care in Africa, IQVIA...
Regional Leadership: Driving Lasting Change in NCD Management
“Localisation.” It’s a term we’ve heard frequently in recent years, but not without its critics—and perhaps rightly so. Many argue that “localisation” doesn’t fully capture the essence of legitimising communities to lead their own health solutions, often implying a...
Integrating NCDs into National Health Plans: Smarter Financing and Buying Strategies
Over the past two decades, noncommunicable diseases (NCDs) and mental health have evolved from niche concerns in global health to central pillars of the sustainable development agenda. Since the 2011 High-level Meeting on the Prevention and Control of NCDs,...
IDA Foundation and FIND to improve access to diagnostics for Noncommunicable Diseases
IDA Foundation and FIND have joined forces to help address the challenges of availability, affordability, and optimal use of diagnostics for Noncommunicable Diseases (NCDs) in low- and middle-income countries (LMICs). IDA Foundation and FIND Partner to Deliver NCD...